Kenta Matsuda

Company: VLP Therapeutics LLC

Job title: R&D Director

Seminars:

Breakthrough Innovations Workshop
Save millions of lives, trillions of dollars, and enable real global equity
3:45 pm

The R3: RNA Readiness and Response program, took a page from the semiconductor industry transformation in the 1980s, which developed multi-product foundries with standardized processes and design tools that exploded global innovation.  This session will cover R3 advances in: Manufacturing processes, with the potential for 10mg to 1kg of RNA-based product, or up to 100…Read more

day: Pre-Conference Day